There was no statistical difference in percentages of CD8+T, CD4+T, CD3+CD56+, NK, B cells, and monocytes between tumor, paratumor, and MNG tissues (Figure S3A), nor between the peripheral blood from PTC and MNG patients (Figure S3B). This evidence concerns the gene CD8A and neoplasm.